 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
ELITE PHARMA INC, (ELI) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Elite Pharmaceuticals, Inc. engages in the research, development, and licensing of proprietary controlled release drug delivery systems and products. The companys products are in various stages of development and testing. Elite entered into an agreement with Purdue Pharma LP to evaluate certain of its abuse resistance technology and to negotiate a license to develop and commercialize oxycodone products under the technology in May 2004. The company was incorporated in 1997 and is based in Northvale, New Jersey.
|
|
|
StreetInsider Alerts
Latest Headlines
ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial (EDGAR Online)
Elite Pharmaceuticals, Inc. Special Stockholders Meeting to be Held On Friday, December 19, 2008 (GlobeNewswire)
Elite Pharmaceuticals, Inc. Hosts Quarterly Conference Call (GlobeNewswire)
ELITE PHARMACEUTICALS INC /DE/ Files SEC form 10-Q, Quarterly Report (EDGAR Online)
ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an (EDGAR Online)
ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Fina (EDGAR Online)
ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an (EDGAR Online)
Elite Pharmaceuticals Elects Wall Street Veteran Jerry Treppel to the Board of Directors (GlobeNewswire)
Stocks Surge as Oil Boosts Energy Stocks (at CNBC)
Stocks Open Slightly Higher, Some Earnings Beat (at CNBC)
|
|
|
